Search Results Page

Wockhardt in the limelight

about 10 years ago

Wockhardt is in the limelight today morning. The stock which has closed yesterday at Rs.894.45, opened at Rs.920, going up to an intra day high of Rs.936.95. The stock now remains 3.5% in the green at Rs.925 levels. For once there is good news from Wockhardt and that too coming from US FDA. ...

Wockhardt caught in FDA turmoil again

about 10 years ago

Somehow, Wockhardt and the US FDA never seem to get off on the right footing. One after the other, the FDA issues keep on cropping up,.

Wockhardt having a muted day

about 9 years ago

Wockhardt is having a very muted kind of trading day today. Its in the red, down less than 1% but given the news which is doing the rounds, it is kind of surprising that the market kind of gave it the ignore.

Wockhardt bounces back

about 7 years ago

For a brief moment of time, Wockhardt notched the spot at the top gainer on the BSE, following its turnaround performance for Q3FY20.

Wockhardt leaving a bitter taste

about 12 years ago

Wockhard is back in the limelight today but once again, for a good reason. Unfortunately, it is once again about a drug recall. The packaging company for Wockhardt in the USA, Blneheim Pharmacal is the one recalling some 166 bottles of Captopril tablets, used in treatment of blood pressure, and C ...

Wockhardt jumps up over 3%

about 8 years ago

Wockhardt showed a sudden spurt of over 3% to Rs.505.15 and it continues to remain in the green.

Wockhardt climbs into the green

about 8 years ago

Wockhardt rose almost 5% today morning to Rs.443. The stock has been gaining for the last 2 days and has risen 4.76% in the period.

Wockhardt bounces back from new low

about 9 years ago

Wockhardt had yesterday hit a new 52-week low at Rs.555 and today it opened higher at Rs.568, going up to Rs.577. It is currently the second top gainer on the BSE.

Wockhardt hits a new low

about 11 years ago

Wockhardt is currently the top loser of the day. It hit a new 52-week low at Rs.1064. Though it has recovered from this level, it remains firmly in the red. The company’s saga with US FDA continues. The company had updated the bourses on 15th Jan evening that US FDA had raised concerns ...

Wockhardt remains top gainer

about 13 years ago

Wockhardt remains stubbornly on the top of the gainers list on the BSE, currently up over 5% at Rs.400.80, with an intra day high at Rs.410.70. Volumes are up almost 1.5 times. The stock, which has been battered down persistently for the past few days, has bounced back into the green today a ...

Wockhardt

about 19 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Wockhardt

about 19 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Wockhardt in good health today

about 12 years ago

Wockhardt is in good health today. The stock opened up with a gap of Rs.84 at Rs.1962 and went on to hit a 52-week high at Rs.1980. The company which has been harrowed by the US FDA, for a change had some good news to offer. It announced yesterday after market closure that the US FDA had ins ...

Wockhardt climbs into the green

about 7 years ago

The stock price has reacted positively to this news and it opened higher 2% at Rs.390.50 and touched an intraday high of Rs.398, rising 4%.

Wockhardt on volatile run

about 5 years ago

Opening higher at Rs.439.60, the stock rose to an intraday high at Rs.464.85 but profit booking at this level, pushed the stock down to the red at Rs.426.30

Wockhardt jumps into green

about 5 months ago

The scrip had jumped over 16% at the open and hit an intraday high of Rs. 2,420, before paring some gains, indicating profit-taking after the initial knee-jerk re-rating. The stock shares extended gains today morning, with the stock up about 12.5% at around Rs. 2,284 in late morning trade after the company received US FDA approval

Wockhardt rises like 'Sputnik'

about 5 years ago

The stock price rose almost 8% higher to hit an intraday at Rs.527, with volumes doubling up. Its 20% UC for the day is at Rs.391.45.

Wockhardt rises like 'Sputnik'

about 5 years ago

The stock reacted very strongly; from its close of Rs.388.05, it opened higher at Rs.402.25, went up to an intraday high at Rs.408.10 and it is now trading at Rs.394 levels.

Wockhardt in news

about 5 years ago

The stock The stock opened 1% higher at Rs.291.50 and rose 3% to hit an intraday high at Rs,298. Its 52-week high and low stands at Rs.741.75 and Rs.287.05

Wockhardt at 5% UC

about 3 years ago

The stock which had closed yesterday at Rs.529.35, opened today at Rs.543 ad rose to Rs.555.80, its 5% UC of the day. Its 52-week high stands at Rs.630.

Wockhardt right on top!

about 10 years ago

Wockhardt is the top gainer since the opening bell today. The stock price rose over 8% to Rs.728 and it remains firmly in the green The company announced yesterday after market closure that Berlin, Germany has since issued EU GMP Certificate confirming that company's manufacturing facilit ...

Wockhardt up almost 5%

about 10 years ago

Wockhardt is the second top gainer on the BSE currently. The stock is up almost 5% at Rs.722 levels with strong rise in volumes. The market is happy that UK MHRA has confirmed that the company's manufacturing unit at Kadaiya, Daman complies with the principles and guidelines of Good Manu ...

Wockhardt at a new high

about 2 years ago

From its close of Rs.686.04, it opened almost 9% higher at Rs.746 and went on to hit a new 52-week high today at Rs.816.35, up 19%.

Wockhardt at new high and UC

about 2 years ago

From its close of Rs.1396.75, the stock opened 1.3% higher and within minutes hit a new high and its 10% UC of the day at Rs.1536.40.

Wockhardt haunted by FDA

about 10 years ago

Wockhardt, as expected, is having a very bad day on the bourses. Hitting an intra day low of Rs.870, it slipped down 14.5%; though it has recovered from there, it remains firmly in the red, down some 10% and amongst the top five losers. The US FDA has once come to haunt the company. This tim ...

Wockhardt up in the green

about 11 years ago

Wockhardt announced late yesterday evening that its manufacturing unit at L-1, Chikalthana, Aurangabad by UK MHRA has since been completed and there were no critical observations. This is the same plant, which earlier got clearance from US FDA which too said about that Chikalthana plant that it h ...

Riding Momentum can Kill an Investor - Wockhardt an Example

about 5 years ago

Hence, request to stop riding momentum, especially on call given by the hourly experts and media anchors.

Wockhardt contiues to lose

about 12 years ago

Wockhardt has been on a weak footing since yesterday and today too, it remains deep in the red. Currently the top loser on the BSE, the stock is down almost 8% at Rs.1227 and thus is after hitting an intra day low at Rs.1181. The market is spooked because the US FDA seems to have come back t ...

Wockhardt shows poor health

about 13 years ago

Wockhardt is down in the deep red today morning, currently 4.5% down at Rs.667.90, with an intra day low at Rs.641. The stock has slipped into the red after the company reported a 78% (YoY) fall in consolidated net profit at Rs.74 crore. Its net sales for the quarter also dropped from Rs.148 ...

Wockhardt in deep red

about 13 years ago

Wockhardt is currently the top loser on the BSE, down 8.3% at Rs.432.90, with an intra day low at Rs.406. Volumes have spiked up over 2.5 times. The stock is deep in the red on account of the same issue of US FDA. There is no official word from the company but news floating around that US FD ...

Wockhardt bounces back

about 13 years ago

Wockhardt which bounced back sharply yesterday, breaching the upper limit at Rs.470.45, is up in the green today too. The stock is currently up at Rs.509, up over 8%, with a 2.7 times spike up in volumes. The stock is up ever since the company, yesterday, stated that Medicine and Healthcare ...

Wockhardt top gainer on BSE

about 13 years ago

Wockhardt is the top gainer on the BSE today morning, up 15% at Rs.532.10, with an intra day high at Rs.546.25. Volumes are huge at almost 3 lakh shares, doubling up from its two week average. The stock has bounced back sharply into the green after the company stated that its promoters - Kho ...

Wockhardt hits the roof

about 13 years ago

Wockhardt, which had been beaten down to pulp over the past few days has bounced back sharply today. The stock which had hit a new 52-week low last week at Rs.344.15 is today locked in the 5% upper circuit at Rs.419.30. The stock hit the roof on news that its Waluj factory which invited the ...

Wockhardt at new low

about 13 years ago

Wockhardt has replaced Gitanjali Gems as the top loser on the BSE. The stock is currently down 9.5% at Rs. 804.85, with an intra day as low as Rs.780. It had hit a new 52-week low on 8th July’13 at Rs.732. The stock has slipped sharply into the red after the company stated that it had ...

Wockhardt in bad health

about 14 years ago

Wockhardt, which was on the 20% lower circuit yesterday, remains the top loser on the BSE currently, down 11%at Rs.1165. Intra day low stands at Rs.1066. The stock is deep in the red after the US FDA issued an import alert at one of its facilities in Aurangabad, Mahrashtra. This is expected ...

THE US FDA SCANNER - MORE GET UNDER

about 12 years ago

This is the thought which comes to mind when we read this news today about Ipca labs also being pulled by the 'villain' of Indian pharma companies - the U.S. Food and Drug Administration (U.S. FDA). The stock is the top loser today on news that the FDA has initiated action at the company's Indore SEZ plant and Ratlam API unit.

CDR - FROM BITTER PILL TO BARFI!

about 14 years ago

Earlier CDR meant the company was close to being declared sick but today, everyone knows the company is in trouble but CDR is like a magic pill that will get the company back into health. This positive perception towards CDR is on account of various past success stories

TULSIANOMICS - THE ART OF MAKING MONEY IN THE MARKET

about 14 years ago

The pursuit of making money is full of perils, especially for a trader. To make life simplier and maybe much richer, our Editor, Mr.SP Tuslian presents a few trading strategies. Follow them to the 'T' and you will not make losses!

CDR - THE NEW PAIN KILLER FOR INDIA INC's INDULGENCES?

about 14 years ago

Debt has become a bad word, taboo on Dalal Street. The moment any company starts showing signs of stress due to high debt, it is dumped like stinking garbage in the dustbin! Companies with high debts always existed and one would have thought that with interest rate cycle now turning downwards, it should actually stop being such a big issue. But in this current environment of bear cartels, margin money pressures and pledged shares

TULSIANOMICS - THE ART OF MAKING MONEY IN THE MARKET

about 13 years ago

The pursuit of making money is full of perils, especially for a trader. To make life simplier and maybe much richer, our Editor, Mr.SP Tuslian presents a few trading strategies. Follow them to the 'T' and you will not make losses!

CDR - AN ESCAPE ROUTE FOR PLANS GONE AWRY

about 13 years ago

As per data on the CDR cell website, since its inception till 31st Dec'13, it has received 605 cases (365 cases as at 31st Dec'11) of which 105 cases were rejected, approving 443 cases. There were 69 cases which exited the CDR successfully while currently 259 cases are 'live'.....

WHEN US FDA MEETS INDIAN PHARMA COMPANIES...

about 9 years ago

This is the thought which comes to mind when we read this news today about Biocon also being pulled by the ‘villain’ of Indian pharma companies – the U.S. Food and Drug Administration (U.S. FDA). The stock was down today as its Bengaluru unit has received ten observations on Form 483 by the FDA. This ranges right from nonconformity to procedures and lack of trained and skilled employees

Life moves on!

about 12 years ago

Last week business news featured some prominent big-ticket acquisition buzz in Corporate India. Be it M&M's likely buy of strategic stake in Pipavav Defence for Rs. 3,000 crore or Sun Pharma founder Dilip Sanghvi's Rs. 4,000 crore investment in wind energy leader Suzlon Energy.

WHY IS THE INDIAN MARKET CRASHING?

about 12 years ago

The stock market has truly crashed and literally fallen through the floor. Falling below 650 points at one point, everyone's heart was in their hands. It was widely expected that the market will actually do well today as the Bombay High Court yesterday stayed the minimum alternate tax (MAT) demand from the income tax department. This stay came purely on 'technical grounds'. The Court stated that it was staying all proceedings against the fund as the Tax department had

CDR CASES DOWN BUT AMOUNT MORE THAN DOUBLES

about 11 years ago

Corporate Debt Restructuring or CDR is hugely popular with traders. The moment a company announces that it is getting into CDR, the stock price zooms up. This is like a patient diagnosed with cancer; the moment one gets to know that chemo and other medications have been started, there is hope and hence optimism.

TURNAROUND IN MOODS - LONG LASTING OR TEMPORARY?

about 14 years ago

Undoubtedly, there is a turnaround in sentiments. From being morose and pessimistic, there is a perceptible shift to hopeful and optimistic. Downgrades and current account be damned; those are thorns which the markets have decided will take once the economy is kick started by the new FM, Dr.Manmohan Singh.

CDR CASES DOWN – THAT’S GOOD NEWS!!

about 9 years ago

Corporate Debt Restructuring or CDR is hugely popular with traders. The moment a company announces that it is getting into CDR, the stock price zooms up. This is like a patient diagnosed with cancer; the moment one gets to know that chemo and other medications have been started, there is hope and hence optim

PRICING OF MEDICINES – HOW MUCH IS TOO MUCH?

about 8 years ago

But it really brings the question back to the fore – how much profit should a drug company make? Given the kind of investment drug companies make in inventing new drugs and patenting, they do deserve a profit. But how much? Is it ethical to squeeze needy patients for as much as it wants?

WELSPUN INDIA - DID IT INDEED SPIN A YARN?

about 10 years ago

As it is those living abroad feel that India is a big con, a jugaadu is our language. Things coming from India are always eyed with suspicion and the reputation is that money is siphoned off from one purpose to the other, with quality taking it on its shoulder. In the country itself, the condition of the roads and various infra projects